Position
Chief Financial Officer
Company
Azora Therapeutics, Inc. (DE)
EncinoBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Adial Pharmaceuticals, Inc. announced the appointment of Vinay Shah as the Company’s Chief Financial Officer, effective November 16, 2024. The current CEO, Cary Claiborne expressed excitement about the new addition and thanked the outgoing CFO, Joseph Truluck, for his contributions.
Quick answer
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer (November 5, 2024). Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Who is the new Chief Financial Officer at Azora Therapeutics, Inc. (DE)?
- Azora Therapeutics, Inc. (DE) named Vinay Shah Chief Financial Officer, announced November 5, 2024.
- What did Azora Therapeutics, Inc. (DE) announce on November 5, 2024?
- Adial Pharmaceuticals, Inc. announced the appointment of Vinay Shah as the Company’s Chief Financial Officer, effective November 16, 2024. The current CEO, Cary Claiborne expressed excitement about the new addition and thanked the outgoing CFO, Joseph Truluck, for his contributions.
- Where is Azora Therapeutics, Inc. (DE) based?
- Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Which similar companies made leadership changes around the same time?
- Tarsus Pharmaceuticals (November 5, 2024), Alkeus Pharmaceuticals (October 31, 2024), Zentalis Pharmaceuticals (November 15, 2024) and Arecor Therapeutics PLC (November 18, 2024) also announced leadership changes within 45 days of Azora Therapeutics, Inc. (DE).
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Zentalis Pharmaceuticals Appoints New CEO and Chief Medical Officer (November 15, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Virpax Pharmaceuticals Appoints Usama Chaudhry as Chief Financial Officer (November 20, 2024)
Who to call at Azora Therapeutics, Inc. (DE), and when
A new leader at Azora Therapeutics, Inc. (DE) brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Azora Therapeutics, Inc. (DE) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Azora Therapeutics, Inc. (DE), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Azora Therapeutics, Inc. (DE). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Azora Therapeutics, Inc. (DE) changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Azora Therapeutics, Inc. (DE) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.